Dr. Mendler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Box Med
Rochester, NY 14642Phone+1 585-275-5823Fax+1 585-273-1051
Education & Training
Ohio State University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2011
University of RochesterResidency, Internal Medicine, 2005 - 2008
University of Rochester School of Medicine and DentistryClass of 2005
Certifications & Licensure
NY State Medical License 2007 - 2025
OH State Medical License 2009 - 2012- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors Start of enrollment: 2017 Aug 07
- A Phase I Pilot Study of Abaloparatide + Bevacizumab in Myelodysplastic Syndromes Start of enrollment: 2019 Feb 14
Publications & Presentations
PubMed
- 3 citationsExercise and epigenetic ages in older adults with myeloid malignancies.Kah Poh Loh, Chandrika Sanapala, Marielle Jensen-Battaglia, Anish Rana, Michael B Sohn
European Journal of Medical Research. 2023-05-30 - 18 citationsManagement of Acute Myeloid Leukemia (AML) in Older PatientsMaya Abdallah, Zhuoer Xie, Audrey Ready, Dharmini Manogna, Jason H. Mendler
Current Oncology Reports. 2020-07-28 - 11 citationsAdaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy.Marissa LoCastro, Chandrika Sanapala, Jason H Mendler, Sally Norton, Rachelle Bernacki
Blood Advances. 2023-05-09
Abstracts/Posters
- Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase...Jason H. Mendler, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
S1712 Supports Adding Ruxolitinib to TKIs for CMLSeptember 20th, 2024
As Leukemia Evolves, Stem Cells Hold Keys to Newer TherapiesAugust 29th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
